Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Early life stress in male mice blunts responsiveness in a translationally-relevant reward task
    Published on 2023-05-31
    3 years ago
  • Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
    Published on 2023-05-31
    3 years ago
  • UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice
    Published on 2023-05-29
    3 years ago
  • How should we design future mechanistic and/or efficacy clinical trials?
    Published on 2023-05-26
    3 years ago
  • Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial
    Published on 2023-05-25
    3 years ago
  • Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
    Published on 2023-05-25
    3 years ago
  • Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice
    Published on 2023-05-23
    3 years ago
« Previous 1 … 127 128 129 130 131 … 143 Next »
Journal of Psychopharmacology
  • Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys
    Published on 2019-10-17
    7 years ago
  • EMD386088 (5 mg/kg) has no effect on latent inhibition shown to both light and noise stimuli
    Published on 2019-10-17
    7 years ago
  • Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia
    Published on 2019-10-03
    7 years ago
  • The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice
    Published on 2019-10-03
    7 years ago
  • Caffeine improves text reading and global perception
    Published on 2019-10-03
    7 years ago
  • Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial
    Published on 2019-10-02
    7 years ago
  • Corrigendum to The Australian Drug Harms Ranking Study
    Published on 2019-10-02
    7 years ago
« Previous 1 … 127 128 129 130 131 … 150 Next »
European Neuropsychopharmacology
  • ‘Microbiota-metabolome interaction in depression: Could it be the new 42?’
    Published on 2021-01-06
    6 years ago
  • Phenotypes of reinforcement sensitivity as predictors of the response to acute antidepressant treatment in rats
    Published on 2021-01-05
    6 years ago
  • Gray matter reorganization underpinnings of antidepressant treatment of persistent depressive disorder
    Published on 2021-01-03
    6 years ago
  • A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder
    Published on 2021-01-03
    6 years ago
  • The “VIP-ADHD trial”: Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?
    Published on 2020-12-31
    6 years ago
  • Contents
    Published on 2020-12-30
    6 years ago
  • Editorial Board
    Published on 2020-12-30
    6 years ago
« Previous 1 … 127 128 129 130 131 … 168 Next »

   Pharma Pub